JP2001526309A5 - - Google Patents

Download PDF

Info

Publication number
JP2001526309A5
JP2001526309A5 JP2000525090A JP2000525090A JP2001526309A5 JP 2001526309 A5 JP2001526309 A5 JP 2001526309A5 JP 2000525090 A JP2000525090 A JP 2000525090A JP 2000525090 A JP2000525090 A JP 2000525090A JP 2001526309 A5 JP2001526309 A5 JP 2001526309A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
fucan
collagen synthesis
proliferation
activate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000525090A
Other languages
English (en)
Japanese (ja)
Other versions
JP4589528B2 (ja
JP2001526309A (ja
Filing date
Publication date
Priority claimed from FR9716080A external-priority patent/FR2772618B1/fr
Application filed filed Critical
Publication of JP2001526309A publication Critical patent/JP2001526309A/ja
Publication of JP2001526309A5 publication Critical patent/JP2001526309A5/ja
Application granted granted Critical
Publication of JP4589528B2 publication Critical patent/JP4589528B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000525090A 1997-12-18 1998-12-17 結合組織の再構築を調節するフカンの用途 Expired - Fee Related JP4589528B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR97/16080 1997-12-18
FR9716080A FR2772618B1 (fr) 1997-12-18 1997-12-18 Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
PCT/FR1998/002758 WO1999032099A2 (fr) 1997-12-18 1998-12-17 Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs

Publications (3)

Publication Number Publication Date
JP2001526309A JP2001526309A (ja) 2001-12-18
JP2001526309A5 true JP2001526309A5 (https=) 2006-01-05
JP4589528B2 JP4589528B2 (ja) 2010-12-01

Family

ID=9514785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000525090A Expired - Fee Related JP4589528B2 (ja) 1997-12-18 1998-12-17 結合組織の再構築を調節するフカンの用途

Country Status (10)

Country Link
US (1) US6559131B1 (https=)
EP (1) EP1039916B8 (https=)
JP (1) JP4589528B2 (https=)
AT (1) ATE255900T1 (https=)
AU (1) AU1764999A (https=)
BR (1) BR9813778A (https=)
DE (1) DE69820480T2 (https=)
ES (1) ES2212833T3 (https=)
FR (1) FR2772618B1 (https=)
WO (1) WO1999032099A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267813A2 (de) * 2000-03-31 2003-01-02 Henkel Kommanditgesellschaft auf Aktien Verwendung von protease-inhibitoren in der kosmetik und pharmazie
US20070238697A1 (en) * 2001-08-29 2007-10-11 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
US6812220B2 (en) * 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
AU2007200318B2 (en) * 2001-08-29 2009-06-18 The University Of British Columbia Use of fucans in the treatment of adhesions, arthritis and psoriasis
EP1870105A1 (en) * 2001-08-29 2007-12-26 The University of British Columbia Use of fucans in the treatment of psoriasis
ES2729826T3 (es) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato
FR2882258B1 (fr) * 2005-02-22 2009-01-16 Oreal Utilisation capillaire de polysaccharides sulfates
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
CN101368178B (zh) * 2007-08-16 2010-07-21 浙江大学 罗氏沼虾精子类明胶酶及其编码基因和应用
WO2010086696A1 (en) 2009-01-28 2010-08-05 Therapol Low-molecular-weight sulphated polysaccharides as candidates for anti-angiogenic therapy
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
JP5946253B2 (ja) * 2011-08-10 2016-07-06 ロート製薬株式会社 弾性線維形成促進剤
FR3020570B1 (fr) * 2014-04-30 2017-07-21 Pierre Fabre Dermo Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
US10569063B2 (en) 2014-10-03 2020-02-25 W. L. Gore & Associates, Inc. Removable covers for drug eluting medical devices
FR3056911B1 (fr) 2016-10-03 2019-07-19 Ys Lab Composition aqueuse derivee d’eau de mer et d’algues marines
FR3113236B1 (fr) 2020-08-05 2024-10-04 Algues Et Mer Fraction purifiée de fucoïdanes pour la préparation de compositions cosmétiques et/ou dermatologiques anti-age.
WO2024243672A1 (en) * 2023-05-31 2024-12-05 ARC Medical Inc. Compositions and methods relating to fucans and modified fucans for the treatment of various medical conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6431707A (en) * 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
IT1275881B1 (it) 1995-03-09 1997-10-24 Res Pharma Srl Polianioni di origine non animale ad attivita' dermatologica e tricogena
FR2738009B1 (fr) * 1995-08-24 1997-10-31 Centre Nat Rech Scient Procede d'obtention de polysaccharides sulfates
JP3914284B2 (ja) * 1996-07-01 2007-05-16 株式会社ヤクルト本社 線維芽細胞増殖因子複合体
JPH1121247A (ja) * 1997-06-30 1999-01-26 Lion Corp 皮膚賦活剤及びアレルギー抑制剤

Similar Documents

Publication Publication Date Title
JP2001526309A5 (https=)
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
HUP0101369A3 (en) Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
AR002974A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparación de una composición cosmética, farmacéutica y/o dermatológica para tratar las manchas rojas cutáneas de origen neurógeno, composición obtenida y procedimiento de tratamiento cosmético empleando dicho antagonista.
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
NO990595D0 (no) Anvendelse av chelateringsmiddelet clikinol ved fremstilling av en farmas°ytisk sammensetning for behandling av alzheimers sykdom
DE68903516D1 (de) Mittel zur senkung des blutdrucks.
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
YU75701A (sh) Farmaceutski preparat
AR066001A2 (es) Producto de emulsion de carne
MXPA05003302A (es) Compuestos de piperazina terapeuticos.
SI1073456T1 (sl) Uporaba osteoprotegerina za preventivo pred kardiovaskularnimi boleznimi in za njihovo zdravljenje
EP1039916B8 (fr) Utilisation d'au moins un fucane pour l'obtention d'un medicament destine au traitement des pathologies parodontales
DE69935853D1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
NZ331953A (en) Benzopyran derivatives having leukotriene-antagonistic action
BG105275A (en) Tan-1057 derivatives
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
FR2723316B1 (fr) Compositions et preparations depigmentantes de la peau, a usages pharmaceutiques ou cosmetiques
MY107235A (en) Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase.
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
ID27755A (id) Komposisi parfum
PL329219A1 (en) Application of benzonaphtene derivatives in production of drugs for treating nervous system diseases
HUP0002826A3 (en) 6-azauracil derivatives, process for producing them, their use for producing medicament useful against inflammatory diseases and such compositions
DE69626691D1 (de) Komponente b als wundheilendes mittel